melior melior discovery melior pharmaceuticals preclinical services pre-clinical services in vivo pharmacology in vivo efficacy efficacy models pharmacokinetics indications discovery specialized animal models bioanalytical services theratrace exton pennsylvania cro contract research drug discovery drug development metabolic disease alzheimer’s alzheimers diabetes reprofiling
Melior Discovery
home
Our Platform
High Throughput In Vivo Pharmacology:
Our Technology
 
 in vivo models in vivo pharmacology

theraTRACE phenotypic screening platform

Melior Pharmaceuticals

              

 

             

 

 melior melior melior discovery melior pharmaceuticals in vivo pharmacology in vivo efficacy efficacy models pharmacokinetics indications discovery specialized animal models theratrace research drug discovery

Our Technology why multiplexing?

Multiplexing is not cassette dosing; rather, it is a proprietary method used to integrate multiple in vivo models. This approach reduces the number of personnel, test subjects and amount of compound required to conduct the screens. The result is an increase in efficiency and a reduction in the overall cost compared to approaches that run assays separately.

If you are interested in learning more about multiplexing, please contact bizdev@meliordiscovery.com to start the conversation.